NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Ace...

FDA Drug Recall #D-0523-2026 — Class II — April 20, 2026

Recall Summary

Recall Number D-0523-2026
Classification Class II — Moderate risk
Date Initiated April 20, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Acella Pharmaceuticals, LLC
Location Alpharetta, GA
Product Type Drugs
Quantity 6,336 bottles

Product Description

NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16

Reason for Recall

Chemical contamination; presence of lead and lithium above specification

Distribution Pattern

Nationwide

Lot / Code Information

Lot: 23F02, Expires: 05/2026; 25A37, Expires: 01/2028.

Other Recalls from Acella Pharmaceuticals, LLC

Recall # Classification Product Date
D-0014-2026 Class II Doxycycline Hyclate Tablets, USP 100 mg*, 500-c... Sep 29, 2025
D-0490-2024 Class III Sodium Sulfacetamide 10% - Sulfur 5% Cleanser, ... Apr 24, 2024
D-0074-2023 Class III Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pa... Nov 14, 2022
D-0069-2023 Class III Phenytoin Sodium Injection, USP 100 mg/2 mL, ND... Nov 14, 2022
D-0070-2023 Class III Phenytoin Sodium Injection, USP, 250 mg/5 mL, N... Nov 14, 2022

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.